The document “Response to ASX Price Query” was lodged with ASX on 9 November, 2021.
Please click to review the full announcement at ASX.
The document “Response to ASX Price Query” was lodged with ASX on 9 November, 2021.
Please click to review the full announcement at ASX.
Bringing molecular specificity to MRI could change the way cancer is diagnosed. We’re proud of the first-of-its-kind technology behind MagSense®, but breakthrough technology alone does
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the
Separating lethal disease from indolent disease remains the persistent difficulty, and molecular MRI may offer a way to see the difference. Prostate cancer is the
We’re on a mission to make cancer more detectable.
